HEALWELL’s current goal is to achieve run rate revenues approaching $100 million by the end of the year from today’s current run rate of over $65 million. This goal is underpinned by a robust M&A pipeline where there are several advanced subjects including one signed LOI and helps the Company position itself to achieve profitability…
HEALWELL is pleased to provide an update on its improved balance sheet with the reduction of approximately $15.5 million of liabilities in Q2-2024. HEALWELL has successfully settled certain payment obligations related to the legacy MCI Medical Clinics Inc. (“MCI Ontario”) business, resulting in extinguishing $3.9 million in future liabilities including rent and operating costs,…
HEALWELL has completed the previously announced acquisitions of both VeroSource Solutions Inc. and BioPharma Services Inc., which boosts HEALWELL’s proforma annualized revenue run-rate to be greater than $65 million and significantly improves HEALWELL’s profitability. Serving five different provincial health clients across Canada, VeroSource is an end-to-end, customizable, cloud-based data interoperability platform that enables patients, care…
HEALWELL has entered into an agreement to acquire BioPharma Services Inc., one of the largest full-service Contract Research Organizations (“CRO”) headquartered in Canada. Biopharma is focused on bioequivalence and early-stage clinical trials, with over 2,200 clinical trials completed to date with approximately 250 pharma clients since inception. BioPharma is expected to generate between $35 to…
Experienced finance and technology executive Anthony Lam joins as the Company’s new Chief Financial Officer. Mr. Lam will replace Mr. Scott Nirenberski who has been CFO since Sept 2020. TORONTO, ON, June 4, 2024 – HEALWELL AI Inc. (“HEALWELL” or the “Company”) (TSX: AIDX) (OTCQX: HWAIF), an AI and data science company focused on preventative…
HEAWELL AI’s Clinical Co-Pilot technology participated in recently published evidence showing the integration of a highly accurate machine model for Chronic Kidney Disease (“CKD”) progression when paired with Electronic Health Record (“EHR”) linked clinical decision support, improves guideline-recommended testing in patients with CKD. HEALWELL’s subsidiary Khure Health (“Khure”) co-authored an abstract that was published this month in…
HEALWELL AI achieved quarterly revenue from continuing operations of $4.58 million in Q1-2024, 132% higher compared to $1.97 million generated in Q1-2023 and 139% higher than $1.92 million generated in Q4-2023. Since its relaunch in Q4-2023 and its acquisition of Intrahealth, an enterprise class EHR service provider on February 1, 2024, the Company’s annual revenue…
HEALWELL AI to hold a conference call and simultaneous webcast on Tuesday, May 14, 2024, at 5:00 pm EDT (2:00 pm PDT). Details on attending:
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, ON, May 06, 2024 – HEALWELL AI INC. (“HEALWELL” or the “Company”) (TSX: AIDX) is pleased to announce today that, due to strong demand, it has agreed with Clarus Securities Inc. (“Clarus”) and Eight Capital Corp. (“Eight”), as Co-Bookrunners and Co-Lead…
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, ON – May 6, 2024 – HEALWELL AI Inc. (“HEALWELL” or the “Company“) (TSX: AIDX), a data science and AI company focused on preventative care, is pleased to announce that it has entered into an agreement pursuant to which…
